AzTrials
AzTrials

Healthy VolunteersNCT03089593

Thermogenic Effect of Ginger

A study testing Extract of ginger in people with Healthy Volunteers, run by Federal University of Minas Gerais at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective of the study is to evaluate the thermogenic effect of ginger. Read more about this study

Who is it for?
Ages 18 to 60 years, women onlyHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
Extract of ginger
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteBrazil
Study dates
27 Mar 2017to 14 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Females;
  • Aged between 18 and 60 years old;
  • Body mass index between 18.5 and 24.9 kg/m²;
  • Agree to sign the informed consent.

Who cannot join

  • Any chronic health conditions (e.g. diabetes, hypertension, chronic renal failure, heart and liver disease);
  • Previous operation for weight loss;
  • Medications known to affect total energy expenditure;
  • Pregnancy and breast-feeding;
  • Smoking;
  • Alcohol use (>2 doses/day).

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital das Clínicas

    Belo Horizonte, Minas Gerais, 30130-100

Other trials in Brazil

About this study

Official title: Double-blind Placebo-controlled Clinical Trial of Thermogenic Effect of Ginger (Zingiber Officinale) in Eutrophic Women

The main objective of the study is to evaluate the thermogenic effect of ginger.

Read the detailed description

Healthy and eutrophic women will receive capsules of 200 mg of ginger extract (5% active ingredient) or placebo (cellulose), along with a standardized breakfast, with a minimum seven days washout period.

Being tested
Extract of ginger, Placebo (Cellulose)
Keywords
Thermic Effect of Food, Energy Expenditure, Ginger

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extract of gingerOther

    The volunteers will receive two capsules containing 200mg of extract of ginger with 5% of gingerols (20 mg). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.

  • Placebo (Cellulose)Other

    The volunteers will receive two capsules containing cellulose (placebo). Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.

Study groups in NCT03089593
Study groupRoleWhat they receive
Extract of gingerExperimentalHealthy and eutrophic women will receive two capsules of 200 mg of ginger extract (5% gingerols) to be taken along with a standardized breakfast.
Receives: Other: Extract of ginger
CellulosePlacebo comparatorHealthy and eutrophic women will receive two capsules of 200 mg of placebo (cellulose) to be taken along with a standardized breakfast.
Receives: Other: Placebo (Cellulose)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in postprandial energy expenditure

    Energy expenditure will be assessed by indirect calorimetry

    Measured: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

Secondary outcomes (7)
  1. Change in oxygen consumption

    Oxygen consumption will be assessed by indirect calorimetry

    Measured: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  2. Change in blood pressure

    Blood pressure will be assessed using digital sphygmomanometer

    Measured: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  3. Change in axillary temperature

    Axillary temperature will be assessed using a digital thermometer

    Measured: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  4. Change in metabolic profile

    Total cholesterol

    Measured: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

  5. Change in heart rate

    Heart rate will be assessed using digital sphygmomanometer

    Measured: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial

  6. Change in metabolic profile

    Glucose levels

    Measured: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

  7. Change in metabolic profile

    HDL-cholesterol

    Measured: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2017
  2. Study start27 Mar 2017
  3. Primary completion14 Jun 2017
  4. Study completion14 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03089593
Sponsor's protocol ID
UFMG 30409114.8.0000.5149
Status last verified
Jun 2017
First submitted
8 Mar 2017
Last updated
21 Jun 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Fagundes GBP, Rodrigues AMDS, Martins LB, Monteze NM, Correia MITD, Teixeira AL, Ferreira AVM. Acute effects of dry extract of ginger on energy expenditure in eutrophic women: A randomized clinical trial. Clin Nutr ESPEN. 2021 Feb;41:168-174. doi: 10.1016/j.clnesp.2020.10.001. Epub 2020 Nov 9.

    PubMed 33487261

Questions about this trial

What is this clinical trial studying?

A study testing Extract of ginger in people with Healthy Volunteers, run by Federal University of Minas Gerais at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in postprandial energy expenditure (time frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03089593, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in